316 related articles for article (PubMed ID: 31134566)
1. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
[TBL] [Abstract][Full Text] [Related]
3. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
Lian W; Jiang B; Qian Z; Pei D
J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
[TBL] [Abstract][Full Text] [Related]
4. Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.
Pei D
ACS Symp Ser Am Chem Soc; 2022; 1417():179-197. PubMed ID: 37621949
[TBL] [Abstract][Full Text] [Related]
5. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
7. Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.
Wen J; Liao H; Stachowski K; Hempfling JP; Qian Z; Yuan C; Foster MP; Pei D
Bioorg Med Chem; 2020 Oct; 28(20):115711. PubMed ID: 33069067
[TBL] [Abstract][Full Text] [Related]
8. Understanding Cell Penetration of Cyclic Peptides.
Dougherty PG; Sahni A; Pei D
Chem Rev; 2019 Sep; 119(17):10241-10287. PubMed ID: 31083977
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide.
Dougherty PG; Wen J; Pan X; Koley A; Ren JG; Sahni A; Basu R; Salim H; Appiah Kubi G; Qian Z; Pei D
J Med Chem; 2019 Nov; 62(22):10098-10107. PubMed ID: 31657556
[TBL] [Abstract][Full Text] [Related]
10. Targeted Subcellular Protein Delivery Using Cleavable Cyclic Cell-Penetrating Peptides.
Schneider AFL; Wallabregue ALD; Franz L; Hackenberger CPR
Bioconjug Chem; 2019 Feb; 30(2):400-404. PubMed ID: 30616339
[TBL] [Abstract][Full Text] [Related]
11. Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.
Salim H; Song J; Sahni A; Pei D
J Org Chem; 2020 Feb; 85(3):1416-1424. PubMed ID: 31609620
[TBL] [Abstract][Full Text] [Related]
12. Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.
González-Muñiz R; Bonache MÁ; Pérez de Vega MJ
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467010
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
14. NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay.
Peier A; Ge L; Boyer N; Frost J; Duggal R; Biswas K; Edmondson S; Hermes JD; Yan L; Zimprich C; Sadruddin A; Kristal Kaan HY; Chandramohan A; Brown CJ; Thean D; Lee XE; Yuen TY; Ferrer-Gago FJ; Johannes CW; Lane DP; Sherborne B; Corona C; Robers MB; Sawyer TK; Partridge AW
ACS Chem Biol; 2021 Feb; 16(2):293-309. PubMed ID: 33539064
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges.
Vinogradov AA; Yin Y; Suga H
J Am Chem Soc; 2019 Mar; 141(10):4167-4181. PubMed ID: 30768253
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity.
Kitagawa H; Kikuchi M; Sato S; Watanabe H; Umezawa N; Kato M; Hisamatsu Y; Umehara T; Higuchi T
J Med Chem; 2021 Apr; 64(7):3707-3719. PubMed ID: 33754721
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
[TBL] [Abstract][Full Text] [Related]
18. Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
D'Souza C; Henriques ST; Wang CK; Craik DJ
Eur J Med Chem; 2014 Dec; 88():10-8. PubMed ID: 24985034
[TBL] [Abstract][Full Text] [Related]
19. Development of a Cyclic, Cell Penetrating Peptide Compatible with In Vitro Selection Strategies.
Abrigo NA; Dods KK; Makovsky CA; Lohan S; Mitra K; Newcomb KM; Le A; Hartman MCT
ACS Chem Biol; 2023 Apr; 18(4):746-755. PubMed ID: 36920103
[TBL] [Abstract][Full Text] [Related]
20. The rational design of cell-penetrating peptides for application in delivery systems.
Kang Z; Ding G; Meng Z; Meng Q
Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
